FSD Pharma Inc. Announces Revolutionary Alcohol Metabolism Beverage Launch
Toronto, ON / ACCESSWIRE / August 9, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) („FSD Pharma“) has recently provided an update on its investment in Celly Nutrition Corp. („Celly Nu“), a Canadian company set to launch an innovative beverage product designed to expedite alcohol metabolism and aid in faster recovery from alcohol consumption. This groundbreaking product, named unbuzzd™, is a result of the collaboration between Celly Nu and FSD Pharma, boasting world-class pharmaceutical research and development.
Led by CEO John Duffy, a former executive at Coca-Cola, and co-chaired by Gerry David, the former CEO of Celsius Holdings (CELH), Celly Nutrition proudly announces the imminent launch of unbuzzd™. This unique beverage is set to revolutionize the recovery drink market by offering a solution to help consumers process alcohol faster, restore mental clarity, and improve cognition after alcohol consumption.
Unlike traditional hangover remedies, unbuzzd™ targets a broader audience of alcohol consumers who value responsible drinking habits and wish to feel great the following day. The beverage is a proprietary blend of vitamins, minerals, and herbs meticulously formulated to support mental alertness, cognitive function, and rapid alcohol metabolism. The product’s development has been driven by a world-class research and development team dedicated to creating an effective, on-the-go formula for accelerated recovery.
The launch of unbuzzd™ will introduce convenient stick packs available in three- and eighteen-pack options on Amazon later this month. These compact packs are designed for portability, allowing consumers to carry them in their pockets or purses for on-the-go use. Whether it’s the end of a long day, a night out with friends, or simply needing a quick recovery dose after alcohol consumption, unbuzzd™ promises to deliver results in as little as 30 minutes. Users can simply add water, shake, and drink for a refreshing and efficient way to cope with the aftermath of alcohol consumption.
Additionally, Celly Nutrition plans to expand the unbuzzd™ product lineup with the introduction of 12oz Ready to Drink (RTD) cans later this year, catering to a wider market of consumers seeking convenient recovery solutions.
The launch of unbuzzd™ is backed by industry experts and luminaries such as Gerry David and John Duffy, who bring a wealth of experience from leading beverage companies. The company has also secured financing to support the launch, issuing common shares for gross proceeds to facilitate business expansion and product development.
FSD Pharma remains committed to developing innovative assets and biotech solutions for challenging neurodegenerative and metabolic disorders, as well as alcohol misuse disorders. The company’s strategic investment in Celly Nutrition underscores its dedication to advancing science-driven solutions that promote individual health and responsible alcohol consumption.
In conclusion, the upcoming launch of unbuzzd™ marks a significant milestone in the wellness and recovery supplement industry. Driven by a commitment to innovation and quality, Celly Nutrition is setting new standards in recovery solutions with the introduction of unbuzzd™. With a strong backing from FSD Pharma and a team of industry experts, unbuzzd™ is poised to make a significant impact on the market and redefine the way consumers approach alcohol consumption recovery.
